atomoxapex syr

Atomoxapex is a pharmaceutical formulation containing Atomoxetine, a selective norepinephrine reuptake inhibitor. It is primarily indicated for the management of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. By increasing the levels of norepinephrine in the brain, it helps improve focus, reduce impulsivity, and manage hyperactivity. This medication is typically prescribed as part of a comprehensive treatment program that may include psychological, educational, and social measures. It is essential to follow the physician's instructions precisely regarding dosage and duration of treatment to ensure safety and efficacy.